Evidence map›Paper›PMID 30190612›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2019

Rare variants in the genetic background modulate cognitive and developmental phenotypes in individuals carrying disease-associated variants.

Lucilla Pizzo, Matthew Jensen, Andrew Polyak, Jill A Rosenfeld, Katrin Mannik, Arjun Krishnan, Elizabeth McCready, Olivier Pichon, Cedric Le Caignec, Anke Van Dijck and 46 more

Open access · hybridAbstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed, 1 pooled it
15.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

112 citing papers in PubMed, 1 synthesis or guideline pooled it, 220 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Quantifying the impact of genetic mutations on enhancer dynamics.bioRxiv : the preprint server for biology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

56 authors at 20 institutions in 9 countries.

Lucilla PizzoDepartment of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, PA, USA.
Matthew JensenDepartment of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, PA, USA.
Andrew PolyakDepartment of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, PA, USA.
Jill A RosenfeldDepartment of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Katrin MannikCenter for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.
Arjun KrishnanDepartment of Computational Mathematics, Science and Engineering, Michigan State University, East Lansing, MI, USA.
Elizabeth McCreadyDepartment of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
Olivier PichonCHU Nantes, Medical genetics department, Nantes, France.
Cedric Le CaignecCHU Nantes, Medical genetics department, Nantes, France.
Anke Van DijckDepartment of Medical Genetics, University and University Hospital Antwerp, Antwerp, Belgium.
Kate PopeDepartment of Paediatrics, Royal Children's Hospital, Murdoch Children's Research Institute and University of Melbourne, Melbourne, Australia.
Els VoorhoeveDepartment of Clinical Genetics, Amsterdam UMC, Amsterdam, The Netherlands.
Jieun YoonDepartment of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, PA, USA.
Paweł StankiewiczDepartment of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Sau Wai CheungDepartment of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Damian PazuchanicsDepartment of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, PA, USA.
Emily HuberDepartment of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, PA, USA.
Vijay KumarDepartment of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, PA, USA.
Rachel L KemberDepartment of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Francesca MariMedical Genetics, University of Siena, Siena, Italy.
Aurora CurróMedical Genetics, University of Siena, Siena, Italy.
Lucia CastigliaOasi Research Institute-IRCCS, Troina, Italy.
Ornella GalesiOasi Research Institute-IRCCS, Troina, Italy.
Emanuela AvolaOasi Research Institute-IRCCS, Troina, Italy.
Teresa MattinaMedical Genetics, University of Catania School of Medicine, Catania, Italy.
Marco FicheraOasi Research Institute-IRCCS, Troina, Italy.
Luana MandaràMedical Genetics, ASP Ragusa, Ragusa, Italy.
Marie VincentCHU Nantes, Medical genetics department, Nantes, France.
Mathilde NizonCHU Nantes, Medical genetics department, Nantes, France.
Sandra MercierCHU Nantes, Medical genetics department, Nantes, France.
Claire BénéteauCHU Nantes, Medical genetics department, Nantes, France.
Sophie BlessonDepartment of genetics, Bretonneau university hospital, Tours, France.
Dominique Martin-CoignardService de Cytogenetique, CHU de Le Mans, Le Mans, France.
Anne-Laure Mosca-BoidronLaboratoire de Genetique Chromosomique et Moleculaire, CHU Dijon, France.
Jean-Hubert CabergCentre Hospitalier Universitaire de Liège. Domaine Universitaire du Sart Tilman, Liège, Belgium.
Maja BucanDepartment of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Susan ZeesmanMcMaster University, Hamilton, Ontario, Canada.
Małgorzata J M NowaczykMcMaster University, Hamilton, Ontario, Canada.
Mathilde LefebvreCentre de Genetique. Hopital d'Enfants Dijon, Dijon, France.
Laurence FaivreCenter for Rare Diseases and Reference Developmental Anomalies and Malformation Syndromes, CHU Dijon, Dijon, France.
Patrick CallierLaboratoire de Genetique Chromosomique et Moleculaire, CHU Dijon, France.
Cindy SkinnerGreenwood Genetic Center, Greenwood, SC, USA.
Boris KerenHopital La Pitie Salpetriere, Paris, France.
Charles PerrineHopital La Pitie Salpetriere, Paris, France.
Paolo PronteraMedical Genetics Unit, Hospital "Santa Maria della Misericordia", Perugia, Italy.
Nathalie MarleLaboratoire de Genetique Chromosomique et Moleculaire, CHU Dijon, France.
Alessandra RenieriMedical Genetics, University of Siena, Siena, Italy.
Alexandre ReymondCenter for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.
R Frank KooyDepartment of Medical Genetics, University and University Hospital Antwerp, Antwerp, Belgium.
Bertrand IsidorCHU Nantes, Medical genetics department, Nantes, France.
Charles SchwartzGreenwood Genetic Center, Greenwood, SC, USA.
Corrado RomanoOasi Research Institute-IRCCS, Troina, Italy.
Erik SistermansDepartment of Clinical Genetics, Amsterdam UMC, Amsterdam, The Netherlands.
David J AmorDepartment of Paediatrics, Royal Children's Hospital, Murdoch Children's Research Institute and University of Melbourne, Melbourne, Australia.
Joris AndrieuxInstitut de Genetique Medicale, Hopital Jeanne de Flandre, CHRU de Lille, Lille, France.
Santhosh GirirajanDepartment of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, PA, USA. sxg47@psu.edu.
Pennsylvania State University · USOasi Maria SS · ITBaylor College of Medicine · USLaboratoire de Génétique Cellulaire · FRMcMaster University · CAAmsterdam University Medical Centers · NLAntwerp University Hospital · BEGreenwood Genetic Center · USUniversity of Lausanne · CHUniversity of Pennsylvania · USUniversity of Siena · ITAzienda Ospedaliera Universitaria Senese · ITCentre Hospitalier du Mans · FRCentre Hospitalier Universitaire de Liège · BECentre Hospitalier Universitaire de Lille · FRIstituti di Ricovero e Cura a Carattere Scientifico · ITMichigan State University · USOspedale Santa Maria · ITPitié-Salpêtrière Hospital · FRSorbonne Université · FR

Funding

Genomic basis of phenotypic variability of genomic disordersR01GM121907 · NIGMS · PENNSYLVANIA STATE UNIVERSITY, THE · PI GIRIRAJAN, SANTHOSH · 2017 to 2025
$5.2M
Computation, Bioinformatics, and Statistics (CBIOS) Training ProgramT32GM102057 · NIGMS · PENNSYLVANIA STATE UNIVERSITY, THE · PI CHIAROMONTE, FRANCESCA, GIRIRAJAN, SANTHOSH · 2013 to 2022
$2.7M
NIGMS NIH HHS R01 GM121907NIGMS NIH HHS T32 GM102057
6 · The paper itself

Abstract

purposeTo assess the contribution of rare variants in the genetic background toward variability of neurodevelopmental phenotypes in individuals with rare copy-number variants (CNVs) and gene-disruptive variants.

methodsWe analyzed quantitative clinical information, exome sequencing, and microarray data from 757 probands and 233 parents and siblings who carry disease-associated variants.

resultsThe number of rare likely deleterious variants in functionally intolerant genes ("other hits") correlated with expression of neurodevelopmental phenotypes in probands with 16p12.1 deletion (n=23, p=0.004) and in autism probands carrying gene-disruptive variants (n=184, p=0.03) compared with their carrier family members. Probands with 16p12.1 deletion and a strong family history presented more severe clinical features (p=0.04) and higher burden of other hits compared with those with mild/no family history (p=0.001). The number of other hits also correlated with severity of cognitive impairment in probands carrying pathogenic CNVs (n=53) or de novo pathogenic variants in disease genes (n=290), and negatively correlated with head size among 80 probands with 16p11.2 deletion. These co-occurring hits involved known disease-associated genes such as SETD5, AUTS2, and NRXN1, and were enriched for cellular and developmental processes.

conclusionAccurate genetic diagnosis of complex disorders will require complete evaluation of the genetic background even after a candidate disease-associated variant is identified.

Indexed as

Genetic Carrier ScreeningAutistic DisorderCalcium-Binding ProteinsCell Adhesion Molecules, NeuronalChromosomes, Human, Pair 16CognitionCytoskeletal ProteinsDNA Copy Number VariationsFemaleGene Expression RegulationGenetic BackgroundHumansMaleMethyltransferasesNerve Tissue ProteinsNeural Cell Adhesion MoleculesAUTS2 protein, humanCalcium-Binding ProteinsCell Adhesion Molecules, NeuronalCytoskeletal ProteinsMethyltransferasesNerve Tissue ProteinsNeural Cell Adhesion MoleculesNRXN1 protein, humanProteinsSETD5 protein, humanTranscription Factors16p11.2 deletionautismCNVmodifierphenotypic variability

Identifiers

PMID30190612
PMCPMC6405313
OpenAlexW2892078296

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.